• Overview
    • Home
    • IR Overview
    • News & Events
      • News
      • Events & Presentations
    • Stock Info
      • Stock Info
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
Skip to main content
IO Biotech

Investor FAQs

  • Overview
    • Home
    • IR Overview
    • News & Events
      • News
      • Events & Presentations
    • Stock Info
      • Stock Info
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
IO Biotech

Mission: Establish our T-win® immune-modulating cancer vaccine as the backbone of combination therapy for people with cancer.

Company

  • Team
  • News
  • Careers
  • Presentations

Science

  • Overview
  • Programs
  • T-win
  • Pipeline
  • Patients

Legal

  • Investors
  • Privacy Policy
  • Cookie Policy
  • Terms of Use

Contact

info@iobiotech.com

Follow us on LinkedIn
© IO Biotech, Inc. - All rights reserved.
Powered By Q4 Inc. 5.112.1.9 (opens in new window)